Recherche
-
GRK2‐ Targeted Knockdown as Therapy for Multiple System Atrophy
(Movement Disorders. vol. 38, n° 7, pp. 1336-1340, 2023-07)Article de revueLibre accès -
Distortion of voiced obstruents for differential diagnosis between parkinson's disease and multiple system atrophy
(Proc. Interspeech 2021, Interspeech Conference, cz, Brno, 2021-08-30)Communication dans un congrès avec actes -
Neurofilament light levels predict clinical progression and death in multiple system atrophy
(Brain - A Journal of Neurology, 2022-07-29)Article de revueLibre accès -
Ambulatory blood pressure and drug treatment for orthostatic hypotension as predictors of mortality in patients with Multiple System Atrophy
(European Journal of Neurology, 2021-12-31)Article de revue -
Staging of progressive supranuclear palsy-Richardson syndrome using MRI brain charts for the human lifespan
(Brain Communications, 2024-02-20)Article de revueLibre accès -
Recent Advances in Clinical Trials in Multiple System Atrophy
(Current Neurology and Neuroscience Reports, 2024-02-28)Article de revue -
An Item Response Theory analysis of the Unified Multiple System Atrophy Rating Scale
(Parkinsonism and Related Disorders. vol. 94, pp. 40-44, 2021-11-30)Article de revue -
Patient-perceived progression in multiple system atrophy: natural history of quality of life
(Journal of Neurology, Neurosurgery and Psychiatry, 2024-03-07)Article de revueLibre accès -
Disease Progression in Multiple System Atrophy: The Value of Clinical Cohorts with Long Follow-Up
(Movement disorders. vol. 38, n° 8, pp. 1567-1569, 2023-08-01)Article de revueLibre accès -
Genome sequence analyses identify novel risk loci for multiple system atrophy
(Neuron, 2024-05-02)Article de revueLibre accès